These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29413000)

  • 1. Protein-Protein Interaction Modulators for Epigenetic Therapies.
    Díaz-Eufracio BI; Naveja JJ; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 110():65-84. PubMed ID: 29413000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating protein-protein interactions: the potential of peptides.
    Nevola L; Giralt E
    Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epigenetic protein-protein interactions with small-molecule inhibitors.
    Linhares BM; Grembecka J; Cierpicki T
    Future Med Chem; 2020 Jul; 12(14):1305-1326. PubMed ID: 32551894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of modulators of protein-protein interactions: current approaches and limitations.
    Meireles LM; Mustata G
    Curr Top Med Chem; 2011; 11(3):248-57. PubMed ID: 21320056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
    Demirel HC; Dogan T; Tuncbag N
    Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to Develop Inhibitors of Motif-Mediated Protein-Protein Interactions as Drug Leads.
    Corbi-Verge C; Garton M; Nim S; Kim PM
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():39-60. PubMed ID: 27618737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide therapeutics: targeting the undruggable space.
    Tsomaia N
    Eur J Med Chem; 2015 Apr; 94():459-70. PubMed ID: 25591543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Druggability assessment of protein-protein interfaces.
    Wanner J; Fry DC; Peng Z; Roberts J
    Future Med Chem; 2011 Dec; 3(16):2021-38. PubMed ID: 22098351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Methods for Epigenetic Drug Discovery: A Focus on Activity Landscape Modeling.
    Naveja JJ; Oviedo-Osornio CI; Medina-Franco JL
    Adv Protein Chem Struct Biol; 2018; 113():65-83. PubMed ID: 30149906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.
    Lu MC; Yuan ZW; Jiang YL; Chen ZY; You QD; Jiang ZY
    Mol Biosyst; 2016 Apr; 12(4):1378-87. PubMed ID: 26935067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
    Rubin S; Qvit N
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrocycles as protein-protein interaction inhibitors.
    Dougherty PG; Qian Z; Pei D
    Biochem J; 2017 Mar; 474(7):1109-1125. PubMed ID: 28298556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drugs that do not target enzyme activity.
    Owen DR; Trzupek JD
    Drug Discov Today Technol; 2014 Jun; 12():e29-34. PubMed ID: 25027371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and under explored epigenetic modulators in search of new paradigms.
    Alam MA; Reddy YS; Ali MA
    Med Chem; 2015; 11(3):271-85. PubMed ID: 25256243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate.
    Anand U; Bandyopadhyay A; Jha NK; Pérez de la Lastra JM; Dey A
    Biofactors; 2023 Mar; 49(2):251-269. PubMed ID: 36326181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.